US equities traded somewhat mixed to lower on Monday, July 20, 2026, as investors balanced rising oil prices, an AI-led factor rotation, and mounting anticipation around upcoming Big Tech earnings. The S&P 500 slipped modestly while the Dow underperformed and the Nasdaq essentially marked time, even as select chip and AI names stabilized after last week’s sharp drawdown.

---

Index recap and risk tone

Wall Street delivered a subdued session characterized by tight intraday ranges and a modest risk-off tilt under the surface. The S&P 500 Index (^GSPC) fell roughly 0.1–0.2%, coming off just its third down week since late March, signaling fatigue rather than outright de-risking at the benchmark level. The Dow Jones Industrial Average (^DJI) declined around 0.5–0.6%, while the Nasdaq Composite (^IXIC) was nearly unchanged, finishing down less than 0.1% as large-cap growth steadied. Small caps bore the brunt of selling pressure, with the Russell 2000 (^RUT) dropping about 0.7%, an extension of a recent pattern in which higher yields and tighter financial conditions weigh more heavily on domestically focused and lower-quality balance sheets. Despite Monday’s softness, the S&P 500 remains up roughly 8–9% year-to-date, the Dow about 8%, and the Nasdaq nearly 10%, underscoring that the primary trend is still higher even as day-to-day leadership grows more fragmented.

---

Macro and commodities: oil back in the driver’s seat

Macroeconomic sentiment was dominated by energy and geopolitics as oil’s grind higher increasingly reasserts itself as a key cross-asset driver. Brent crude (BZ=F) pushed higher again after briefly easing, rebounding toward the 90-dollar area following tit-for-tat military actions involving the United States and Iran and heightened tensions around shipping in the Strait of Hormuz. Houthi militants’ declaration of a “maritime embargo” against Saudi Arabia is raising concerns about potential chokepoints in global crude flows, even as futures prices remain below their April–May peaks, suggesting markets still assume some rerouting capacity and supply flexibility. Higher oil prices are feeding directly into Treasury yields, which continued to edge up on Monday and added incremental pressure on rate-sensitive equities, including small caps and more leveraged cyclicals. For equity investors, the macro setup remains a balancing act: on one side, resilient growth and robust nominal demand support earnings, especially in energy and select cyclicals; on the other, the combination of higher input costs and elevated real yields tightens financial conditions at the margin and raises the hurdle rate for long-duration growth stories.

---

AI, semis, and the Big Tech earnings overhang

The AI trade spent the day searching for a new catalyst rather than cascading lower, as leading semiconductor and AI-adjacent names stabilized after last week’s valuation-driven shakeout. Chip stocks broadly firmed, helping keep the Nasdaq near flat even as broader indices drifted lower, a sign that investors are selectively re-engaging after forced or risk-managed de-risking in prior sessions. Yet sentiment remains fragile, with an ongoing global reassessment of stretched AI valuations evidenced by steep drawdowns in some Asia-Pacific benchmarks and AI-linked names, including the nearly 4.5% selloff in South Korea’s Kospi as local investors trimmed high-flying AI exposures.

Heading into the heart of earnings season, the market’s focus is squarely on whether mega-cap platforms can convert AI narratives into tangible monetization. Street expectations have been ratcheted higher for Alphabet Inc. (GOOG, GOOGL), Intel Corporation (INTC), International Business Machines Corporation (IBM), and Tesla Inc. (TSLA), with investors looking for evidence that capex-heavy AI build-outs are now unlocking incremental revenue, margin expansion, or durable ecosystem advantages. The bar is now meaningfully higher for forward guidance: commentary around AI workloads, cloud optimization, inference demand, and data-center efficiency is likely to matter as much as headline EPS beats or misses.

---

Single‑stock spotlight: AMC’s fundamental comeback

AMC Entertainment Holdings Inc. (AMC) emerged as a high-beta outperformer, with shares surging more than 11% intraday and opening above 2 dollars as the theater chain delivered its strongest quarter in company history. The company reported second-quarter 2026 adjusted earnings of 0.14 dollars per share, dramatically outperforming consensus expectations that had called for a 0.04 dollar loss, as both top line and profitability surprised to the upside. Revenue climbed 14% year over year to 1.59 billion dollars, ahead of the 1.5 billion dollar Wall Street forecast, while adjusted EBITDA jumped 70% to roughly 321.4 million dollars, surpassing the 300 million dollar mark for the first time and underscoring operating leverage as attendance improves. Management highlighted that more than 4.3 million moviegoers visited AMC’s U.S. AMC Theatres and international ODEON circuits over the Thursday–Sunday window, driven by the record-shattering opening of Christopher Nolan’s “The Odyssey,” produced and distributed by Universal Pictures, a division of Comcast Corporation (CMCSA). “The Odyssey” generated an estimated 124.5 million dollars in domestic box office and 139.6 million dollars internationally for a global debut of roughly 264.1 million dollars, marking the strongest opening weekend of Nolan’s career and delivering AMC its biggest R-rated opening across its U.S. circuit since 2024. In sympathy, IMAX Corporation (IMAX) gained around 3.2% and Cinemark Holdings Inc. (CNK) rose about 3.6%, illustrating how a robust tentpole slate can lift the broader exhibition complex even as AMC’s equity remains nearly 99% below its 2021 meme-stock peak.

---

Takeaways for investors and content positioning

From an investor’s lens, Monday’s tape reinforces several themes: macro remains dominated by energy and geopolitics; AI is transitioning from pure narrative to proof-of-monetization; and pockets of the real economy—such as theatrical exhibition via AMC, IMAX, and CNK—are quietly demonstrating cyclical recovery and operating leverage. For institutional allocators, the setup argues for maintaining a barbelled posture: pairing quality growth exposure in AI and cloud platforms like GOOG, GOOGL, INTC, IBM, and TSLA with selective cyclicals and energy, while remaining wary of the drag from higher real yields on small caps and lower-quality balance sheets.

VP Watchlist Updates

Amwell® (NYSE: AMWL)

Amwell® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, closed at $12.58.

Hudson Pacific Properties (NYSE: HPP)

Hudson Pacific Properties (NYSE: HPP, $14.75) is a real estate investment trust serving dynamic tech and media tenants in global epicenters for these synergistic, converging and secular growth industries. Hudson Pacific’s unique and high-barrier tech and media focus leverages a full-service, end-to-end value creation platform forged through deep strategic relationships and niche expertise across identifying, acquiring, transforming and developing properties into world-class amenitized, collaborative and sustainable office and studio space.

Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Inc. (EPRX, $6.24) a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced (July 7) the appointment of Robert Bazemore, Amy Pottand Dr Helen Thackray to the Board of Directors. “We are delighted for Robert, Amy and Helen to join our Board of Directors at a pivotal stage for the company.”   said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “Their collective expertise across late-stage drug development, commercial strategy, and global product launches will be invaluable as we execute on several key upcoming milestones for EP-104GI and continue to expand our pipeline. Their appointments reflect the commitment of Eupraxia to advancing and expanding our gastroenterology assets in an efficient and effective manner. I also want to thank Paul Geyer and Michael Wilmink for all of the support and contributions they have made to Eupraxia over the last decade as we proved the function and potential of the Diffusphere technology.”

Eupraxia announced (May 5) the first Eosinophilic Esophagitis Endoscopic Reference Score (EREFS) data from its ongoing Phase 1b/2a part of the RESOLVE trial evaluating EP-104GI for the treatment of eosinophilic esophagitis (“EoE”). These data were also presented at the ongoing Digestive Disease Week (“DDW”) conference in Chicago. “The EREFS is an important, validated visual index of severity of EoE disease in the esophagus of patients. It measures edema, rings and strictures and other visible markers of disease often associated with symptoms. Today’s data demonstrated improvement in two key outcomes with EP-104GI in the treatment of EoE: first, that a full injection protocol of 20 injections resulted in more pronounced improvement than a protocol with fewer injections and less coverage area within the esophagus; second, with the higher number of injections, a consistent response in both the inflammatory and fibrotic sub scores of EREFS was observed,” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “This EREFS data being reported at DDW is consistent with the improvements we have seen in EoE symptoms and tissue health (EoEHSS) and suggests improvement in inflammation, fibrosis and the associated narrowing of the esophagus.”

Modular Medical, Inc. (NASDAQ: MODD)

Modular Medical, Inc. (NASDAQ: MODD, $2.64), a leader in innovative, patient-centric insulin delivery, released findings (July 15) from an independent market research study demonstrating positive receptivity to its FDA-cleared Pivot™ tubeless patch pump due to its differentiated design, streamlined user experience, and potential for reimbursement through the pharmacy channel.

Modular Medical announced (July 14) announced positive findings from a new comprehensive diabetes patient research initiative further supporting its commercialization strategy. The Company will share these findings and showcase its Pivot™ tubeless insulin patch pump at the upcoming Association of Diabetes Care & Education Specialists (ADCES) Annual Conference in Columbus, Ohio, August 7-10, 2026. Key findings from the assessment of 100 individuals utilizing multiple daily injections revealed significant unmet needs and strong interest in simplified insulin pump technology: 1) 97% of participants stated they would be interested in insulin pump therapy and expressed openness to alternative treatment options, 2) Among the 43% of participants who reported being hospitalized due to hyperglycemia, hypoglycemia, diabetic ketoacidosis (DKA), or hyperosmolar hyperglycemic state (HHS), nearly half reported experiencing such events two or more times annually, & 3) 55% of participants reported finding themselves in environments that were not convenient or private for administering insulin injections at least twice per week, while 31% experienced these situations more than four times per week.

Modular Medical (June 30) announced that the first patients have completed onboarding and training and are now actively using the Pivot™ tubeless insulin patch pump in real-world settings. This milestone marks the transition of the Pivot pump from development into active patient use and represents a significant step in Modular Medical’s commercialization strategy. The Company will now begin collecting real world utilization data and user feedback to support broader adoption and continued product deployment optimization.

MODD announced ( June 26) that the Pivot™ tubeless insulin patch pump is now shipping to physician offices for training. Upon completion of training, these pumps will be presented to potential patients in the next few days and weeks. The Company intends to expand the roster of practices that offer Pivot over the coming months. This is another significant milestone in the deployment of Pivot. Modular Medical looks forward to updating the market when these first patients are using the pump to deliver insulin. The Pivot pump is purpose-built for adults with diabetes on daily injections who have faced cost, complexity, and usability barriers with traditional pump systems. This group represents an estimated 70% of insulin-dependent adults who remain on multiple daily injections, a multi-billion-dollar opportunity within the diabetes technology market.

MODD announced (June 24) that the Pivot™ tubeless insulin patch pump is now commercially available. This marks the start of real-world patient use, and the Company’s transition to a commercial-stage medical device company. As only the second fully electronic, tubeless insulin pump available in the United States, Pivot is designed to make pump therapy simpler to learn and easier to live with. Its removable two-part design and 3 mL reservoir, intuitive interface, and flexible, wearable form factor support everyday activities, such as showering and sports, with no battery recharging required – all while maintaining clinical accuracy and connectivity. “Reaching commercial availability is a transformational milestone that marks Modular Medical’s transition from a development-stage company to a revenue-generating commercial business,” said Jeb Besser, Chief Executive Officer of Modular Medical. “As only the second fully electronic tubeless pump on the U.S. market, Pivot is positioned to serve a large, underserved ‘almost-pumper’ population. With first shipments beginning this week, we are focused on disciplined execution, as we scale adoption and seek to build long-term value for patients and shareholders.”

Similarweb Ltd. (NYSE: SMWB)

Similarweb Ltd. (NYSE: SMWB, $6.69), a leading digital data and analytics company powering critical business decisions, announced (June 15) that it has surpassed $300 million in Annual Recurring Revenue (ARR) and signed two multi-year enterprise contracts, each representing seven-figure ARR commitments. Collectively, these contracts represent approximately $47 million in Total Contract Value to be recognized over the next three years and were signed during the second quarter of 2026.

NVIDIA (NVDA)

NVIDIA (NVDA) closes at $203.28, +.23%.

The InterGroup Corporation (INTG)

The InterGroup Corporation (NASDAQ: INTG), a diversified holding company with interests in hospitality, real estate, and marketable securities. InterGroup consolidates its majority‑owned subsidiary Portsmouth Square, Inc., which owns the Hilton San Francisco Financial District hotel and related facilities, closed at $38.60.

LG Display Co., Ltd. (LPL)

LG Display Co., Ltd. (NYSE: LPL, $3.19) has spent the last few years doing something many hardware companies talk about but few execute well: turning a technology pivot into a full‑blown business transformation that everyday investors can actually follow. Instead of chasing commoditized LCD TV panels in a race to the bottom, LPL is leaning into Gaming OLED, CES‑worthy innovation, and premium automotive displays – and the press trail tells a surprisingly investor‑friendly story.

Yatsen Group (NYSE: YSG)

Yatsen Group (NYSE: YSG, $3.52), a world-class beauty innovation pioneer, announced (July 8) a landmark collaboration to bring its flagship brand, Perfect Diary, to Sephora in China. This partnership integrates Yatsen’s rigorous scientific infrastructure with the world’s leading prestige beauty retailer, marking a significant milestone in Yatsen’s continuing evolution into a global beauty technology powerhouse.

Doximity, Inc. (NYSE:DOCS)

Doximity (NYSE: DOCS, $21.73, +.98% is the leading digital platform for U.S. medical professionals. The company’s network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits.

The Sources

[1] Stock market today: Dow, S&P 500, Nasdaq mixed as oil rises, Big Tech earnings loom https://finance.yahoo.com/markets/live/stock-market-today-monday-july-20-dow-sp-500-nasdaq-oil-111429441.html
[2] How major US stock indexes fared Monday 7/20/2026 https://www.seattletimes.com/business/how-major-us-stock-indexes-fared-monday-7-20-2026/
[3] World shares are mixed and South Korea’s Kospi drops 4.5% as some AI stocks swoon https://www.mysanantonio.com/news/world/article/south-korea-s-kospi-drops-nearly-5-as-some-ai-22351788.php
[4] Asia stocks mixed as investors reassess AI bets; S Korea slides, China outperforms By Investing.com https://uk.investing.com/news/stock-market-news/asia-stocks-mixed-as-investors-reassess-ai-bets-s-korea-slides-china-outperforms-4777205?ampMode=1
[5] AMC Stock Soars On Earnings And The Odyssey https://www.youtube.com/watch?v=QeHwtKNFBnU
[6] Stock market today: Dow, S&P 500, Nasdaq mixed as chip stocks rise in wait for Big Tech earnings https://finance.yahoo.com/markets/live/stock-market-today-monday-july-20-dow-sp-500-nasdaq-111429441.html
[7] US Markets Open Mixed; Chip Stocks Recover Small Fraction of AI Loss https://ts2.tech/en/us-markets-open-mixed-chip-stocks-recover-small-fraction-of-ai-loss/
[8] Europe close: Stocks mixed as investors watch oil markets https://www.sharecast.com/news/market-report-europe-close/europe-close-stocks-mixed-as-investors-watch-oil-markets–23073354.html
[9] World shares are mixed and South Korea’s Kospi drops 4.5% as some AI stocks swoon https://www.mcalesternews.com/region/world-shares-are-mixed-and-south-koreas-kospi-drops-4-5-as-some-ai-stocks/article_a0f878f7-d1d9-5652-a77d-e2d06d1ec5ed.html
[10] Stock Market Today: Live Updates 20.07.2026 https://ts2.tech/en/stock-market-today-20-07-2026/
[11] Asian markets mixed as AI selloff deepens; South Korea’s Kospi slides nearly 5% https://www.emirates247.com/business/asian-markets-mixed-as-ai-selloff-deepens-south-koreas-kospi-slides-nearly-5/3788
[12] Stock Market Today (July 20, 2026): S&P 500 climbs as U.S. … https://www.thestreet.com/stock-market-today/stock-market-today-dow-jones-sp-500-nasdaq-updates-july-20-2026